These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 17130680

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Anti-IgE antibody therapy for Japanese cedar pollinosis: omalizumab update.
    Okubo K, Nagakura T.
    Allergol Int; 2008 Sep; 57(3):205-9. PubMed ID: 18724074
    [Abstract] [Full Text] [Related]

  • 4. Omalizumab is more effective than suplatast tosilate in the treatment of Japanese cedar pollen-induced seasonal allergic rhinitis.
    Nagakura T, Ogino S, Okubo K, Sato N, Takahashi M, Ishikawa T.
    Clin Exp Allergy; 2008 Feb; 38(2):329-37. PubMed ID: 18070163
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of omalizumab on symptoms of seasonal allergic rhinitis: a randomized controlled trial.
    Casale TB, Condemi J, LaForce C, Nayak A, Rowe M, Watrous M, McAlary M, Fowler-Taylor A, Racine A, Gupta N, Fick R, Della Cioppa G, Omalizumab Seasonal Allergic Rhinitis Trail Group.
    JAMA; 2001 Dec 19; 286(23):2956-67. PubMed ID: 11743836
    [Abstract] [Full Text] [Related]

  • 9. Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitis.
    Chervinsky P, Casale T, Townley R, Tripathy I, Hedgecock S, Fowler-Taylor A, Shen H, Fox H.
    Ann Allergy Asthma Immunol; 2003 Aug 19; 91(2):160-7. PubMed ID: 12952110
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis.
    Kuehr J, Brauburger J, Zielen S, Schauer U, Kamin W, Von Berg A, Leupold W, Bergmann KC, Rolinck-Werninghaus C, Gräve M, Hultsch T, Wahn U.
    J Allergy Clin Immunol; 2002 Feb 19; 109(2):274-80. PubMed ID: 11842297
    [Abstract] [Full Text] [Related]

  • 11. Effectiveness of fluticasone furoate 110 microg once daily in the treatment of nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollen.
    Jacobs R, Martin B, Hampel F, Toler W, Ellsworth A, Philpot E.
    Curr Med Res Opin; 2009 Jun 19; 25(6):1393-401. PubMed ID: 19419338
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of sublingual immunotherapy for two seasons in patients with Japanese cedar pollinosis.
    Okamoto Y, Okubo K, Yonekura S, Hashiguchi K, Goto M, Otsuka T, Murata T, Nakao Y, Kanazawa C, Nagakura H, Okawa T, Nakano K, Hisamitsu M, Kaneko S, Konno A.
    Int Arch Allergy Immunol; 2015 Jun 19; 166(3):177-88. PubMed ID: 25895909
    [Abstract] [Full Text] [Related]

  • 15. The co-seasonal application of anti-IgE after preseasonal specific immunotherapy decreases ocular and nasal symptom scores and rescue medication use in grass pollen allergic children.
    Rolinck-Werninghaus C, Hamelmann E, Keil T, Kulig M, Koetz K, Gerstner B, Kuehr J, Zielen S, Schauer U, Kamin W, Von Berg A, Hammermann J, Weinkauf B, Weidinger G, Stenglein S, Wahn U, Omalizumab Rhinitis Study Group.
    Allergy; 2004 Sep 19; 59(9):973-9. PubMed ID: 15291906
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma.
    Kopp MV, Hamelmann E, Zielen S, Kamin W, Bergmann KC, Sieder C, Stenglein S, Seyfried S, Wahn U, DUAL study group.
    Clin Exp Allergy; 2009 Feb 19; 39(2):271-9. PubMed ID: 19016798
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Preventative effect of a flavonoid, enzymatically modified isoquercitrin on ocular symptoms of Japanese cedar pollinosis.
    Hirano T, Kawai M, Arimitsu J, Ogawa M, Kuwahara Y, Hagihara K, Shima Y, Narazaki M, Ogata A, Koyanagi M, Kai T, Shimizu R, Moriwaki M, Suzuki Y, Ogino S, Kawase I, Tanaka T.
    Allergol Int; 2009 Sep 19; 58(3):373-82. PubMed ID: 19454839
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.